"Designing Growth Strategies is in our DNA"

U.S. Viral Clearance Market Size, Share & Industry Analysis, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method), By Application (Blood and Blood Products, Recombinant Proteins, Cellular & Gene Therapy Products, Vaccines, and Others), By End-user (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CRO), and Others), and Country Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI107888

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Technological Advancements in Viral Clearance Methods
    2. Regulatory Scenario, U.S.
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    4. Impact of COVID-19 on the Market
  5. U.S. Viral Clearance Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Method
      1. Viral Removal Method
      2. Viral Inactivation Method
      3. Viral Detection Method
    2. Market Analysis, Insights and Forecast – By Applications
      1. Blood and Blood Products
      2. Recombinant Proteins
      3. Cellular & Gene Therapy Products
      4. Vaccines
      5. Others
    3. Market Analysis, Insights and Forecast – By End-user
      1. Pharmaceutical and Biotechnology Companies 
      2. Academic & Research Institutes
      3. Contract Research Organizations (CRO)
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Merck KGaA
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Wuxi Biologics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Charles River Laboratories
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Texcell
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Kedrion
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Clean Cells
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. ViruSure GmbH
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Sartorius AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Syngene International Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      10. Microbiologics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Table 01: U.S. Viral Clearance Market Revenue (USD million) Forecast, By Method, 2019-2032

Table 02: U.S. Viral Clearance Market Revenue (USD million) Forecast, By Application, 2019-2032

Table 03: U.S. Viral Clearance Market Revenue (USD million) Forecast, By End-user, 2019-2032

Table 04: U.S. Viral Clearance Market Revenue (USD million) Forecast, By Region, 2019-2032

 

Figure 01: U.S. Viral Clearance Market Revenue Breakdown (USD million, %) by Method, 2023 & 2032

Figure 02: U.S. Viral Clearance Market Value Share (%), By Method, 2023 & 2032

Figure 03: U.S. Viral Clearance Market Value Share (%), By Application, 2023 & 2032

Figure 04: U.S. Viral Clearance Market Value Share (%), By End-user, 2023 & 2032

Figure 05: U.S. Viral Clearance Market Value Share (%), By Region, 2023 & 2032

Figure 06: U.S. Viral Clearance Market Share (%), By Company, 2023

  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Consulting Services
    How will you benefit from our consulting services ?